Ritaskrá Háskóla Íslands - 01.05.2008, Blaðsíða 284

284

Thompson A, Watson S, Wensley F, White IR, Wood AM. The Emerging Risk Factors
Collaboration: analysis of individual data on lipid, inflammatory and other markers in
over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J
Epidemiol. 2007;22(12):839-69.
Gunnarsdottir I, Aspelund T, Birgisdottir BE, Benediktsson R, Gudnason V, Thorsdottir I.
Infant feeding patterns and midlife erythrocyte sedimentation rate. Acta Paediatr. 2007
Jun;96(6):852-6.
Sarwar N, Sattar N, Gudnason V, Danesh J. Circulating concentrations of insulin markers and
coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart
J. 2007 May 17; [Epub ahead of print].
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB,
Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S,
Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen
Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC,
Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH,
Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O,
Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. A variant in
CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007 Apr 26;
770-775.
Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E,
Jousilahti P, Knekt P, Koskela P, Kyyronen PP, Lenner P, Luostarinen T, Love A,
Ogmundsdottir H, Stattin P, Tenkanen L, Tryggvadottir L, Virtamo J, Wadell G, Widell
A, Lehtinen M, Dillner J. Nordic biological specimen banks as basis for studies of cancer
causes and control - more than 2 million sample donors, 25 million person years and 100
000 prospective cancers. Acta Oncol. 2007;46(3):286-307.
Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson
G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V. Age,
Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied Phenomics.
Am J Epidemiol. 2007;165(9):1076-87.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM,
Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158
incident cases among 262,525 participants in 29 Western prospective studies. Circulation.
2007 Jan 30;115(4):450-8.
Thrainsdottir IS, Aspelund T, Gudnason V, Malmberg K, Sigurdsson G, Thorgeirsson G,
Hardarson T, Rydén L.Increasing Increasing glucose levels and BMI predict future heart
failure experience from the Reykjavík Study. Eur J Heart Fail. 2007 Oct;9(10):1051-7.
Steingrimsdottir H, Haraldsdottir V, Olafsson I, Gudnason V. Monoclonal gammopathy:
natural history studied with a retrospective approach. Haematologica. 2007
Aug;92(8):1131-4.
Bergsveinsson J, Aspelund T, Gudnason V, Benediktsson R. Prevalence of type 2 diabetes
mellitus in Iceland 1967-2002 Laeknabladid. 2007 May;93(5):397-402.
Siggeirsdottir K, Aspund T, Sigurdsson G, Mogensen B, Chang M, Jonsdottir B, Eiriksdottir
G, Launer LJ, Harris TB, Jonsson BY, Gudnason V. Inaccuracy in self-report of fractures
may underestimate association with health outcomes when compared with medical record
based fracture registry. Eur J Epidemiol. 2007;22(9):631-9.